Biohaven Pharmaceuticals

5 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

Warren Volles

General Counsel & Chief Legal Officer

George Clark

VP, Chief Accounting Officer

Robert Croop

Chief Development Officer, Neurology

Bruce D. Car

Chief Scientific Officer

Tova Gardin

Chief Translational Officer

Cliff Bechtold

President & GM, Biohaven Ireland, Chief Compliance Officer

Matthew Buten

Chief Financial Officer

Elyse Stock

Senior Scientific Advisor

St John Donnie McGrath

Chief of Corporate Strategy & Business Development

David Stock

VP, Biostatistics

Michael Bozik

President, Ion Channel Research & Development

Melissa Beiner

Director, R&D

Wes Kazmierski

Senior Director, Chemistry

Katy Mcgrath

Principal Scientist, In Vivo Science

David Weaver

SVP, Neuroscience & Pharmacology

Kimberly Gentile

SVP, Clinical Operations

Teams

+39

Leadership Team

42 members

+36

Clinical Operations Team

39 members

+26

Research and Development Team

29 members

Legal and Compliance Team

7 members

Offices

This company has no offices yet

Similar companies

Twist Bioscience

12 followers

Thermo Fisher Scientific

173 followers

Verily Life Sciences

38 followers

Guardant Health

13 followers

Sarepta Therapeutics

9 followers

Ascendis Pharma

8 followers

AGC Biologics

4 followers

Strand Life Sciences

3 followers

Merck

225 followers

AbbVie

189 followers

Inari

3 followers

Explore companies